Key facts
- Notable investors include Yikon Genomics.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Ruishou Pets
- ·The full record, as it builds
Funding rounds
No funding rounds for Ruishou Pets are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ruishou Pets
Provider of biotechnology-driven animal care solutions intended for genetic screening and reproductive optimization. The company offers embryo engineering, single-cell genome amplification, and intelligent service systems, serving the high-end pet breeding market to reduce hereditary disease incidence, enhance rare breed propagation, and establish a standardized, health-focused lifecycle management model through data-driven diagnostics, certification, and supply chain integration.
- Sector
- Healthcare
- HQ
- Huangshan, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Ruishou Pets doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ruishou Pets shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ruishou Pets in its N-PORT filings yet. We sweep new filings monthly.